Are There Therapies Targeting Pro Inflammatory Signals?
Targeting pro inflammatory signals is an area of active research. Anti-inflammatory drugs like nonsteroidal anti-inflammatory drugs (NSAIDs) have shown promise in reducing cancer risk and progression. Additionally, specific inhibitors of cytokines such as anti-TNF-α therapies and IL-6 inhibitors are being explored for their potential to suppress tumor-promoting inflammation. Immunotherapies that modulate the immune response by targeting pro inflammatory pathways are also under investigation.
